LM-49

N/A

Report date: 2025/02/27 16:29:40
NME

Base Information

Drug NameLM-49
Drug Alias Name5,2'-Dibromo-2,4',5'-trihydroxydiphenylmethanone
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionT-cell surface antigen CD4 modulators
TargetsT-cell surface antigen CD4
Therapy Area/IndicationsDiabetic Nephropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanxi University Of Traditional Chinese MedicineShanxi Medical University
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShanxi University Of Traditional Chinese MedicineShanxi Medical University
Inactive CompaniesN/A
Active IndicationsDiabetic Nephropathies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A